MedTrace Logo

Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion

NCT04267770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2020-03-31

Study results available
· View outcomes & findings →

Summary

Randomised controlled trial to contribute to the evidence base for the optimal initial insulin profile for adults with type 1 diabetes commencing insulin pump therapy.

Conditions

Interventions

DRUG

Insulin (circadian)

Participant's own insulin adjusted to circadian infusion rates

DRUG

Insulin (flat rate)

Participant's own insulin set to flat basal rates

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-10
Primary Completion
2018-11-09
Completion
2018-11-09

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267770 on ClinicalTrials.gov